A detailed history of Fishman Jay A LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Fishman Jay A LTD holds 33,727 shares of JNJ stock, worth $4.87 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
33,727
Previous 42,709 21.03%
Holding current value
$4.87 Million
Previous $6.24 Million 12.45%
% of portfolio
0.54%
Previous 0.66%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$145.48 - $167.38 $1.31 Million - $1.5 Million
-8,982 Reduced 21.03%
33,727 $5.47 Million
Q2 2024

Aug 05, 2024

BUY
$144.38 - $157.78 $5.32 Million - $5.81 Million
36,819 Added 625.11%
42,709 $6.24 Million
Q2 2024

Jul 31, 2024

SELL
$144.38 - $157.78 $7.78 Million - $8.5 Million
-53,866 Reduced 90.14%
5,890 $860,000
Q1 2024

Apr 23, 2024

SELL
$155.22 - $162.74 $4.07 Million - $4.26 Million
-26,199 Reduced 30.48%
59,756 $9.45 Million
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $718,827 - $784,390
-4,937 Reduced 5.43%
85,955 $13.5 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $3.25 Million - $3.64 Million
-20,886 Reduced 18.69%
90,892 $14.2 Million
Q2 2023

Aug 15, 2023

SELL
$154.35 - $166.11 $4.67 Million - $5.03 Million
-30,252 Reduced 21.3%
111,778 $18.5 Million
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $2,114 - $2,523
-14 Reduced 0.01%
142,030 $22 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $343,629 - $385,649
2,145 Added 1.53%
142,044 $25.1 Million
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $309,753 - $344,678
1,920 Added 1.39%
139,899 $22.9 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $121,096 - $133,927
-720 Reduced 0.52%
137,979 $24.5 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $513,954 - $583,667
3,250 Added 2.4%
138,699 $24.6 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $1.16 Million - $1.28 Million
7,418 Added 5.79%
135,449 $23.2 Million
Q3 2021

Nov 08, 2021

SELL
$161.5 - $179.47 $577,362 - $641,605
-3,575 Reduced 2.72%
128,031 $20.7 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $395,669 - $424,424
2,481 Added 1.92%
131,606 $21.7 Million
Q1 2021

May 03, 2021

SELL
$153.07 - $170.48 $4,898 - $5,455
-32 Reduced 0.02%
129,125 $21.2 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $193,187 - $221,748
1,409 Added 1.1%
129,157 $20.3 Million
Q3 2020

Nov 10, 2020

SELL
$140.38 - $153.83 $431,668 - $473,027
-3,075 Reduced 2.35%
127,748 $19 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $171,574 - $207,139
-1,332 Reduced 1.01%
130,823 $18.4 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $2.23 Million - $3.09 Million
-20,070 Reduced 13.18%
132,155 $17.3 Million
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $1.62 Million - $2.25 Million
14,604 Added 10.61%
152,225 $20 Million
Q4 2019

Feb 04, 2020

SELL
$127.5 - $146.44 $1.07 Million - $1.23 Million
-8,404 Reduced 5.76%
137,621 $20.1 Million
Q3 2019

Nov 05, 2019

SELL
$126.95 - $142.14 $431,630 - $483,275
-3,400 Reduced 2.28%
146,025 $18.9 Million
Q2 2019

Aug 06, 2019

SELL
$131.15 - $144.24 $367,220 - $403,872
-2,800 Reduced 1.84%
149,425 $0
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $322,220 - $358,281
2,563 Added 1.71%
152,225 $0
Q4 2018

Feb 05, 2019

SELL
$122.84 - $147.84 $335,844 - $404,194
-2,734 Reduced 1.79%
149,662 $19.3 Million
Q3 2018

Oct 31, 2018

SELL
$121.58 - $142.88 $382,977 - $450,072
-3,150 Reduced 2.03%
152,396 $0
Q2 2018

Aug 06, 2018

SELL
$119.4 - $131.76 $17,910 - $19,764
-150 Reduced 0.1%
155,546 $0
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $250,575 - $296,724
-2,003 Reduced 1.27%
155,696 $0
Q4 2017

Feb 05, 2018

SELL
$131.22 - $143.62 $187,644 - $205,376
-1,430 Reduced 0.9%
157,699 $0
Q3 2017

Oct 31, 2017

BUY
$129.47 - $135.38 $20.6 Million - $21.5 Million
159,129
159,129 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.